Apellis Pharmaceuticals I... (APLS)
Apellis Pharmaceuticals Max Pain By Strike
APLS trades at $27.05, 4.0% above the near-term max pain of $26 expiring Sep 19, 2025 (31 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($16-$30), signaling increased put positioning or downside protection. Key magnetic zone at 20 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Apellis Pharmaceuticals Max Pain By Expiry
Max pain for APLS shows a downward trend from 30 to 16, indicating bearish sentiment or hedging activity. The 63% spread signals divergent expectations across timeframes. Most levels below 27.05 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 26 | -1.05 (-3.88%) |
| Oct 17, 2025 | 20 | -7.05 (-26.06%) |
| Jan 16, 2026 | 20 | -7.05 (-26.06%) |
| Apr 17, 2026 | 16 | -11.05 (-40.85%) |
| Jan 15, 2027 | 30 | 2.95 (10.91%) |